HMGCR and autoimmune disease: From public databases, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) was predicted as the downstream target of miR-146b-3p, which was previously demonstrated to be associated with the therapy of autoimmune diseases [19, 20].